ERLOTAD(Erlotinib)
Therapeutic class: kinase inhibitor
- Locally advanced or metastatic non-small cell lung cancer (NSCLC)
- Locally advanced, unresectable or metastatic Pancreatic Cancer
100 mg & 150 mg Tablets
100 mg:- A bottle of 10 tablets150 mg:- A bottle of 10 tablets
- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
